R. Fedorak

Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial

S. Hanauer, P. Rutgeerts, W. Sandborn, 2007, Gut.

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

R. Fedorak, R. Bailey, M. Poleski, 1997, Gastroenterology.